2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow D961H capsule 10mg: new trials by email Literature Review of D961H capsule 10mg trials Research Report on D961H capsule 10mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer D961H capsule 10mg, D961H sachet 10mg - Reflux Esophagitis, Gastric Ulcer | Phase 3 | Completed | AstraZeneca | 50 | 2018-07-24 | 2026-03-04 |
| A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases D961H sachet 10 mg, D961H capsule 10mg, D961H capsule 20 mg - Gastric Ulcer (GU), Duodenal Ulcer (DU) | Phase 3 | Completed | AstraZeneca | 55 | 2014-06-01 | 2017-01-19 |
Duodenal Ulcer (2) · Esophagitis, Peptic (2) · Stomach Ulcer (2) · Zollinger-Ellison Syndrome (1)
AstraZeneca (2)
Japan (2)
Toshiaki Shimizu, M.D., Ph.D. (1)
2018 (1)